Local News: Franklin, NH 

 | 

Sign Up

 | 

Sign In

Advertisment

OSI Pharmaceuticals

OSI Pharmaceuticals News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make OSI Pharmaceuticals News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

OSI Pharmaceuticals News

News on OSI Pharmaceuticals continually updated from thousands of sources around the net.

Friday | Business Wire

Public relations, press release distribution, investor relations, SEC filing

GAITHERSBURG, Md.-- --OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group , announced today that the U.S. F... LISLE, Ill.-- --Claymore Dividend & Income Fund , a non-diversified closed-end management investment company, declared a year... WASHINGTON-- --Jim McGregor, Vice Chairman of The McGregor Metalworking ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Genentech, US Energy Systems, Energy, Springfield, OH, Dayton Metro, Westlake, OH

Thu Dec 17, 2009

American Chronicle

News and FDA Updates for Merck

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Food and Drug Administration, Law, Biotech, Merck , Medicine, Healthcare Industry, Genentech, Health, Lung Cancer, Opinion

Wed Dec 16, 2009

North Jersey Media Group

FDA panel votes down new use for OSI cancer drug

Federal health advisers recommended Wednesday against expanding approval of an OSI Pharmaceuticals lung cancer drug to patients who are already responding to chemotherapy.

Comment?

Related Topix: Biotech, Food and Drug Administration, Medicine, Healthcare Industry, Health, Lung Cancer, Pancreatic Cancer, Genentech, Startups

Newsday

Growth at Enzo gives hope for LI bio-tech industry

Back in July, when Long Island's largest biotechnology company, OSI Pharmaceuticals Inc.

Comment?

Related Topix: Enzo Biochem, Biotech, Medicine, Healthcare Industry, Melville, NY, Westchester County, NY, Farmingdale, NY, Opinion

Mon Dec 14, 2009

Miami Herald

FDA says OSI drug effective against lung cancer

After a lifetime of Hollywood success, actress Farrah Fawcett had the misfortune to die from one of the rarest malignancies, anal cancer.

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, Food and Drug Administration, Healthcare Industry, Lung Cancer, Breast Cancer, Colorectal Health, Colon Cancer

Bioscience Technology

FDA says OSI drug effective against lung cancer

Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy.

Comment?

Related Topix: Biotech, Food and Drug Administration, Medicine, Healthcare Industry, Health, Lung Cancer

BioSpace

Us Fda Staff: Roche Holding Ag, Osi Pharmaceuticals, Inc.'s Tarceva Effective for Wider Use

Tarceva, co-marketed by Roche Holding AG and OSI Pharmaceuticals met the main goals in a study testing effectiveness when given to lung cancer patients immediately after chemotherapy, U.S. drug reviewers said in documents released on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Lung Cancer

Tue Dec 08, 2009

BioResearch Online

Seven New Biopharmaceutical Research Companies Join PhRMA's...

As part of its efforts to expand awareness of the importance of medical progress in the United States, the Pharmaceutical Research and Manufacturers of America is announcing today the addition of seven new member companies.

Comment?

Related Topix: Biotech, Medicine, Cubist Pharmaceuticals, Healthcare Industry, Raleigh, NC

Fri Nov 20, 2009

American Chronicle

Updates for OSI Pharmaceuticals

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Perrigo, Opinion

Tue Nov 17, 2009

American Chronicle

News and FDA Updates for NovaDel

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Neogen, Health, Lung Cancer, Opinion

Mon Nov 16, 2009

M2.com

OSI says Tarceva to be reviewed by FDA committee for use as...

OSI says Tarceva to be reviewed by FDA committee for use as first-line maintenance therapy in advanced NSCLC Published in M2Europharma on Monday, 16 November 2009 at 21:09 GMT 16 November 2009 - US-based OSI Pharmaceuticals Inc said today that FDA's Oncologic Drugs Advisory Committee will review the use of Tarceva as a first-line maintenance ...

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Health, Lung Cancer

Fri Oct 30, 2009

The China Stock Blog

China Biotech Week in Review: International Initiatives

There was a particularly strong international flair to news from China biopharma last week.

Comment?

Related Topix: Medicine, Healthcare Industry, World News, China, Asia, Biotech, Marketing, Stem Cell Research, Science / Technology

Wed Oct 28, 2009

Bloomberg Business News

Galleon Is Said to Have Liquidated More Than 90% of Hedge-Fund Investments

Galleon Group LLC, the hedge-fund firm thata s liquidating after billionaire founder Raj Rajaratnam was charged with insider trading, sold more than 90 percent of its investments, according to a person familiar with the matter.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Oct 27, 2009

TheStreet.com

ETFs Reshaped Ahead of Regulation

As negative sentiment against Wall Street snowballs and a new trading scandal takes shape, it is important to look back to 1986 and reflect on what's changed and what hasn't. While traders at the Galleon Group began unwinding positions in stocks like eBay , Apple and OSI Pharmaceuticals in the wake of Raj Rajaratnam's arrest, the filming of "Wall ...

Comment?

Related Topix: Financial Markets, Computers, Apple Computer, Biotech, Medicine, Healthcare Industry, Mutual Funds, Personal Finance, Business News

Sun Oct 25, 2009

BayStreet.ca

AllPennyStocks.com News: Large & Small-Cap Companies Making Big...

AllPennyStocks.com News: Large & Small-Cap Companies Making Big Strides In The Fight Against Cancer MISSISSAUGA, Ontario, October 19, 2009 -- AllPennyStocks.com Media, Inc.

Comment?

Related Topix: Canada, Biotech, Medicine, Healthcare Industry, Eli Lilly, Health, Breast Cancer, Financial Markets

Fri Oct 23, 2009

American Chronicle

News and FDA Updates for Dynavax

Pasadena, CA - 10/22/09 - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Pasadena, CA, Startups, Dynavax Technologies, Biotech, Medicine, Healthcare Industry, Opinion

Thu Oct 22, 2009

Miami Herald

OSI Pharma 3rd-qtr profit falls on costs, taxes

Shares of drug developer OSI Pharmaceuticals Inc. rallied Thursday after the company posted better-than-expected revenue in the third quarter, even as its profit plunged on higher costs and taxes.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

The Biotech Stock Blog

OSI Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript

OSI Pharmaceuticals, Inc. October 21, 2009 5:00 pm ET Executives Kathy Galante a ' Senior Director, Investor and Public Relations Pierre Legault a ' EVP, CFO and Treasurer Gabriel Leung a ' EVP and President, Pharmaceutical Business Colin Goddard a ' CEO Analysts Harry [ph] a ' JP Morgan Vlad Agassi [ph] a ' Cowen Presentation Operator Please stand ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Scientific Instruments, Semiconductors, Electronics, OSI Systems

Wed Oct 21, 2009

The Biotech Stock Blog

Simcere to Develop OSI Pharmaceutical Cancer Drug in China

Simcere Pharmaceutical Group has acquired the China rights to a dual-mechanism cancer drug from OSI Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cancer, Health, Simcere Pharmaceutical, Lung Cancer

New York Times

Westchester Slowly Lures Biotech Companies

After more than six years of courting the biotech industry, Westchester County is getting some positive results.

Comment?

Related Topix: Biotech, Science / Technology, New York Metro, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Business News

Franklin Jobs

Also on Topix